Results

Total Results: 1,065 records

Showing results for "analyzing".

1. Executive Summary_Systematic Review: Association of Digestible Carbohydrate Intake With Cardiovascular Disease, Type 2 Diabetes, Obesity, and Body Composition (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/effect-dietary-digestible-executive-summary.pdf
   March 01, 2025 - Analyzing carbohydrate intake as a percentage of total energy intake showed a gradual decrease in the … Similarly, analyzing carbohydrate intake in grams per day revealed a steady decline in CVD risk up to … Analyzing carbohydrate intake as a percentage of total energy intake showed a relatively flat risk of … Similarly, analyzing carbohydrate intake in grams per day revealed a 5 flat CHD … Similarly, analyzing carbohydrate intake in grams per day showed a reduced risk up to 260 grams per

2. Methods Guide for Medical Test Reviews (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-metaanalysis_methods.pdf
   July 01, 2012 - We briefly outline common approaches for meta- analyzing medical tests, and discuss principles for choosing … Why could directly meta-analyzing likelihood ratios be problematic? … and specificity rarely results in different conclusions.24 What should be said about directly meta-analyzing … Characteristics of Meta-Analysis Methods Over several decades many methods have been used for meta-analyzing … negative likelihood ratios from summary estimates of sensitivity and specificity, rather than meta-analyzing

3. Effective Health Care (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0095_04-10-2009.pdf
   January 01, 2009 - In addition to analyzing the existing research, the final report will focus on defining the evidence

4. S166 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/s166.pdf
   October 01, 2007 - This method of analyzing indirect comparisons is sim- ple and straightforward and preserves the randomization … We combined these studies and the 3-arm trials (ie, trials analyzing BNZ, NBNZ, and placebo) included … In the current study, the indirect estimate included only 2-arm trials (ie, trials analyzing either BNZ … becomes particularly useful in this instance, as it yields a straightforward method of simultaneously analyzing

5. Misuse of Prescription Stimulants in Adults (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-prescription-protocol.pdf
   September 13, 2024 - No Problem: Analyzing Black Market Sales of Atomoxetine on StreetRx. medRxiv. 2022. 9. … Analyzing Black Market Sales of the Second-Line ADHD Medication Atomoxetine.

6. Appendix-E-Evidence-Tables-E1-E4 0 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Evidence-Tables-E1-E4_0.xlsx
   May 29, 2025 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…

7. Cannabis-App-F1-F4-Tables-Surveillance-Report-2 0 0 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2_0_0.xlsx
   May 29, 2025 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…

8. App-E-Surv-Report-2-Nonopioid-Pharmacol-Chronic-Pain (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
   May 29, 2025 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…

9. Cannabis-2022-Update-Surv-Rep-1-App-F1-4 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F1-4.xlsx
   January 01, 2022 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…

10. Cer-250-Cannabis-Tables-E1-E4-2022-Update 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-tables-e1-e4-2022-update_0.xlsx
    January 01, 2022 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…

11. Misuse of Prescription Stimulants in Adults (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-prescription-protocol-amendment.pdf
    November 26, 2024 - No Problem: Analyzing Black Market Sales of Atomoxetine on StreetRx. medRxiv. 2022. 9. … Analyzing Black Market Sales of the Second-Line ADHD Medication Atomoxetine.

12. Cannabis-2023-Surv-Rep-4-Tables-E-1-E-4 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
    January 01, 2023 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…

13. Cannabis-2023-Surv-Rep-1-App-F (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
    January 01, 2023 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…

14. Cannabis-2022-Surv-Rep-4-Tables-F1-4 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
    January 01, 2022 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…

15. Cannabis-2022-Surv-Rep-3-Tables-F1-4 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
    January 01, 2022 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…

16. Meta-analysis of Test Performance Evidence When There is a “Gold Standard” Reference Standard (ppt file)
    effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-meta-analysis.ppt
    June 01, 2012 - Meta-analyzing each metric across studies will create summaries that are inconsistent with these formulas … Deciding Which Metrics To Meta-analyze (2 of 6) This figure illustrates the strategy for meta-analyzing … Why can directly meta-analyzing positive and negative likelihood ratios be problematic? … Recommended Algorithm A three-step algorithm is recommended for meta-analyzing studies of medical test … range of prevalence values) from summary estimates of sensitivity and specificity, rather than meta-analyzing

17. Meta-analysis of Test Performance Evidence When There is a “Gold Standard” Reference Standard (ppt file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-meta-analysis.ppt
    June 01, 2012 - Meta-analyzing each metric across studies will create summaries that are inconsistent with these formulas … Deciding Which Metrics To Meta-analyze (2 of 6) This figure illustrates the strategy for meta-analyzing … Why can directly meta-analyzing positive and negative likelihood ratios be problematic? … Recommended Algorithm A three-step algorithm is recommended for meta-analyzing studies of medical test … range of prevalence values) from summary estimates of sensitivity and specificity, rather than meta-analyzing

18. App-E-Surv-Report-1-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…

19. Cover Page (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicine-safety-call-center_research.pdf
    September 01, 2007 - of a web based drug effectiveness reporting and monitoring system that builds on previous studies analyzing … database is available for download by clinical reviewers and researchers on a quarterly basis for analyzing … Previous Work Several studies have been conducted analyzing the use of Information Technology (IT) … There is relatively limited literature analyzing the use of information technology for large scale

20. Cover Page (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/it-architecture-for-post-marketing-surveillance-arizona-cert.pdf
    September 01, 2007 - of a web based drug effectiveness reporting and monitoring system that builds on previous studies analyzing … database is available for download by clinical reviewers and researchers on a quarterly basis for analyzing … Previous Work Several studies have been conducted analyzing the use of Information Technology (IT) … There is relatively limited literature analyzing the use of information technology for large scale